# China NMPA Drug Inspection - Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. - Amoxicillin capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/sinopharm-group-shantou-jinshi-pharmaceutical-co-ltd/c7e744af-c5b3-4ffa-a83b-b114a199e591/
Source feed: China

> China NMPA drug inspection for Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Amoxicillin capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Amoxicillin capsules
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/sinopharm-group-shantou-jinshi-pharmaceutical-co-ltd/f74c1945-c1a6-457a-b75b-b5171a85bb0b/